Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 27

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 27
---
 purchase and in such case,
you will suffer immediate dilution based on the difference between the price you pay per share of our common stock and our net tangible
book value per share at the time of your purchase. As of October 31, 2025, our net tangible book value per share, excluding all liability
classified warrants was $3.11.

| S-15 |

Raising additional funds by issuing securities or through licensing arrangements may cause dilution to stockholders, restrict our operations or require us to relinquish proprietary rights.

To the extent that we raise additional capital
through the sale of equity or convertible debt securities, stockholders will be diluted, and the terms of these new securities may include
liquidation or other preferences that adversely affect the rights of common stockholders.

Debt financing, if available at all, may involve
agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making
capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or licensing arrangements
with third parties, we may have to relinquish valuable rights to our technologies, product candidates or future revenue streams or grant
licenses on terms that are not favorable to us. We may also seek to access the public or private capital markets whenever conditions are
favorable, even if we do not have an immediate need for additional capital at that time. There can be no assurance that we will be able
to obtain additional funding if, and when necessary. If we are unable to obtain adequate financing on a timely basis, we could be required
to delay, curtail or eliminate one or more, or all, of our development programs or grant rights to develop and market product candidates
that we would otherwise prefer to develop and market ourselves.

Sales of a significant number of shares of our common stock in the public markets, or the perception that such sales could occur, could depress the market price of our common stock.

Sales of a significant number of shares of our
common stock in the public markets, or the perception that such sales could occur could depress the market price of our common stock and
impair our ability to raise capital through the sale of additional equity securities. Furthermore, sales of a substantial number of our
common stock in the public market following this offering could cause the market price of our common stock to decline and could impair
our ability to raise capital through the sale of additional equity securities. We cannot predict the effect that future sales of our common
stock or